D.E. Shaw & Co’s Foundation Medicine, Inc. FMI Stock Holding History

D.E. Shaw & Co’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-36,300	Closed	-$4.96M	–	4135
2018 Q2	$4.96M	Buy	36,300 +32,227	+791%	+$2.93M	0.01%	1543
2018 Q1	$321K	Sell	4,073 -70,539	-95%	-$5.2M	﹤0.01%	3116
2017 Q4	$5.09M	Buy	+74,612	New	+$3.87M	0.01%	1479
2017 Q1	–	Sell	-12,258	Closed	-$217K	–	3747
2016 Q4	$217K	Sell	12,258 -69	-0.6%	-$1.49K	﹤0.01%	3245
2016 Q3	$288K	Buy	+12,327	New	+$280K	﹤0.01%	3065
2016 Q2	–	Sell	-19,397	Closed	-$353K	–	3645
2016 Q1	$353K	Buy	+19,397	New	+$313K	﹤0.01%	2956
2014 Q1	–	Sell	-8,628	Closed	-$280K	–	4812
2013 Q4	$206K	Buy	+8,628	New	+$241K	﹤0.01%	4256

D.E. Shaw & Co's FMI Position: Q3 2018 in Review

D.E. Shaw & Co sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 36,300 shares — an estimated $4.96M sold.

D.E. Shaw & Co first reported a position in FMI in Q4 2013 and held it in 7 quarters. The position peaked at $5.09M in Q4 2017. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

D.E. Shaw & Co reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
D.E. Shaw & Co sold 36,300 Foundation Medicine, Inc. shares in Q3 2018, an estimated $4.96M.
D.E. Shaw & Co first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 7 quarters.
D.E. Shaw & Co's Foundation Medicine, Inc. position peaked at $5.09M in Q4 2017.
0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on D.E. Shaw & Co's 13F filing for Q3 2018, filed 14 Nov 2018.